stockrow
Friday 6 November 2026
Export PFE’s income statement to Excel — free account
Pfizer Inc.
PFE Healthcare Drug Manufacturers General
Pfizer Inc.’s revenue for fiscal 2025 (year ended December 2025) was $62.6 billion, down 1.65% from fiscal 2024.
- Revenue
- −0.43%
- EPS
- −7.98%
- Free cash flow
- +20.0%
- Total debt
- +1.55%
Quarter to September 2026, against a year earlier
29.32
0.56
−1.87%
Follow PFE
Alert me
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
18.31 | 18.70 | 82.58 | 9.20 | 15.14 | 21.40 | 13.16 | 22.70 | 9.98 | 27.57 |
Piotroski F-Score |
6 | 8 | 3 | 6 | 7 | 6 | 6 | 5 | 6 | 6 |
Altman Z-Score |
2.03 | 2.02 | 1.70 | 3.76 | 3.62 | 2.69 | 2.39 | 2.87 | 2.61 | 2.22 |
P/S ratio |
2.26 | 2.36 | 2.82 | 2.84 | 4.07 | 4.91 | 5.21 | 6.14 | 4.05 | 3.72 |
P/FCF ratio |
17.10 | 16.63 | 42.00 | 11.39 | 11.38 | 17.97 | 21.07 | 18.30 | 14.66 | 13.89 |
Altman Z″-Score (non-manufacturers) |
3.19 | 3.14 | 2.30 | 4.59 | 3.97 | 3.39 | 2.63 | 3.51 | 3.32 | 2.70 |
Beneish M-Score |
(2.52) | (2.71) | (2.37) | (2.34) | (1.98) | (2.52) | (2.63) | (2.88) | (2.39) | (2.68) |
P/Operating CF |
26.46 | 22.36 | 32.02 | 33.50 | 55.92 | 36.35 | 56.59 | 52.88 | 30.00 | 32.52 |
Dividend Safety Score |
28 | — | — | — | — | — | — | — | — | — |
P/B ratio |
1.63 | 1.70 | 1.88 | 3.00 | 4.27 | 3.22 | 3.36 | 3.93 | 2.97 | 3.28 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 245.28 | 106.42 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
3.08 | 3.05 | 3.81 | 2.97 | 4.16 | 5.57 | 6.25 | 6.70 | 4.49 | 4.18 |
EV/EBITDA |
9.25 | 9.99 | 29.99 | 7.36 | 13.73 | 17.95 | 20.52 | 23.13 | 11.81 | 12.33 |
EV/Operating CF |
16.46 | 15.23 | 26.09 | 10.27 | 10.38 | 16.11 | 20.32 | 17.28 | 14.05 | 13.63 |
EV/FCF |
23.28 | 21.49 | 56.83 | 11.91 | 11.63 | 20.40 | 25.27 | 19.97 | 16.28 | 15.60 |
Quick Ratio |
0.69 | 0.74 | 0.51 | 0.80 | 1.00 | 0.78 | 0.44 | 0.84 | 0.93 | 0.84 |
Current Ratio |
1.16 | 1.17 | 0.91 | 1.22 | 1.40 | 1.35 | 0.88 | 1.57 | 1.35 | 1.25 |
Net Debt/EBITDA |
2.46 | 2.26 | 7.82 | 0.32 | 0.30 | 2.14 | 3.41 | 1.94 | 1.18 | 1.35 |
Debt/Assets |
31.13% | 30.16% | 31.74% | 18.17% | 21.18% | 25.83% | 31.12% | 26.18% | 25.32% | 24.52% |
Debt/Equity |
0.75 | 0.73 | 0.81 | 0.37 | 0.50 | 0.63 | 0.82 | 0.65 | 0.61 | 0.70 |
Asset Turnover |
0.30 | 0.29 | 0.28 | 0.53 | 0.48 | 0.26 | 0.25 | 0.25 | 0.31 | 0.31 |
Operating CF/Net income |
1.51 | 1.59 | 4.11 | 0.93 | 1.48 | 1.57 | 0.79 | 1.42 | 0.79 | 2.24 |
Capex/Depreciation |
(0.40) | (0.41) | (0.62) | (0.64) | (0.52) | (0.59) | (0.43) | (0.35) | (0.35) | (0.35) |
| 8.87% | 9.03% | 2.29% | 36.19% | 31.19% | 14.43% | 25.20% | 16.48% | 32.42% | 11.56% | |
| 3.69% | 3.65% | 1.00% | 16.57% | 13.09% | 5.69% | 9.80% | 6.73% | 12.41% | 4.26% | |
ROIC |
6.45% | 5.86% | 0.54% | 20.52% | 14.32% | 5.66% | 3.96% | 4.09% | 9.01% | 9.03% |
Return on Tangible Assets |
30.80% | 31.18% | 14.63% | 123.54% | 68.89% | 40.01% | 189.25% | 35.46% | 86.69% | 34.11% |
Average Days of Receivables |
69.26 | 65.76 | 70.89 | 39.51 | 51.54 | 69.34 | 60.43 | 71.75 | 57.11 | 56.83 |
Research and Development Expense of Revenue |
16.68% | 17.01% | 17.93% | 11.30% | 12.74% | 20.91% | 20.50% | 19.01% | 14.62% | 14.94% |
Selling, General and Administrative Expense of Revenue |
22.04% | 23.15% | 24.80% | 13.52% | 15.63% | 27.84% | 31.11% | 30.89% | 28.17% | 28.10% |
Intangible Assets out of Total Assets |
0.60 | 0.58 | 0.59 | 0.48 | 0.41 | 0.51 | 0.49 | 0.56 | 0.61 | 0.62 |
Share Based Compensation of Revenue |
1.28% | 1.38% | 0.88% | 0.86% | 1.45% | 1.81% | 1.68% | 2.26% | 1.60% | 1.31% |
Graham Net Nets |
(0.55) | (0.50) | (0.56) | (0.17) | (0.13) | (0.27) | (0.33) | (0.18) | (0.28) | (0.37) |
Graham Number |
21.62 | 22.33 | 11.32 | 46.30 | 34.84 | 21.03 | 27.31 | 21.43 | 31.05 | 16.08 |
Earnings Yield |
5.46% | 5.35% | 1.21% | 10.87% | 6.60% | 4.67% | 7.60% | 4.41% | 10.02% | 3.63% |
Free Cash Flow Yield |
5.85% | 6.01% | 2.38% | 8.78% | 8.79% | 5.56% | 4.75% | 5.46% | 6.82% | 7.20% |
Revenue per Share |
11.01 | 11.23 | 10.55 | 18.04 | 14.51 | 7.50 | 7.35 | 6.95 | 8.80 | 8.68 |
Operating CF per Share |
2.06 | 2.25 | 1.54 | 5.22 | 5.82 | 2.59 | 2.26 | 2.70 | 2.81 | 2.66 |
Capex per Share |
(0.46) | (0.51) | (0.69) | (0.58) | (0.48) | (0.50) | (0.44) | (0.36) | (0.37) | (0.33) |
Free Cash Flow per Share |
1.60 | 1.74 | 0.85 | 4.64 | 5.33 | 2.10 | 1.82 | 2.33 | 2.44 | 2.33 |
Cash per Share |
2.39 | 3.62 | 2.25 | 4.05 | 5.55 | 2.20 | 1.73 | 3.21 | 3.35 | 2.93 |
Shareholders Equity per Share |
15.27 | 15.62 | 15.82 | 17.10 | 13.83 | 11.43 | 11.39 | 10.86 | 12.00 | 9.83 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
15.27 | 15.62 | 15.82 | 17.10 | 13.83 | 11.43 | 11.39 | 10.86 | 12.00 | 9.83 |
Free Cash Flow |
9,075.00 | 9,835.00 | 4,793.00 | 26,031.00 | 29,869.00 | 11,638.00 | 10,124.00 | 13,691.00 | 14,585.00 | 14,193.00 |
Working Capital |
5,914.00 | 7,363.00 | (4,461.00) | 9,121.00 | 17,022.00 | 9,147.00 | (4,501.00) | 18,068.00 | 10,714.00 | 7,834.00 |
Capital Expenditures |
(2,629.00) | (2,909.00) | (3,907.00) | (3,236.00) | (2,711.00) | (2,765.00) | (2,464.00) | (2,136.00) | (2,217.00) | (1,999.00) |
Net Current Asset Value |
(78,487.00) | (74,541.00) | (93,880.00) | (50,029.00) | (44,320.00) | (55,689.00) | (71,345.00) | (45,738.00) | (59,000.00) | (72,827.00) |
EV/EBIT |
13.53 | 15.64 | 177.45 | 8.40 | 17.40 | 28.13 | 38.12 | 48.21 | 17.21 | 18.17 |
Capex to Sales |
0.04 | 0.05 | 0.07 | 0.03 | 0.03 | 0.07 | 0.06 | 0.05 | 0.04 | 0.04 |
Price to Operating Income |
9.93 | 12.11 | 131.17 | 8.03 | 17.02 | 24.79 | 31.79 | 44.17 | 15.50 | 16.17 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.34 | 0.38 | 0.33 | 0.31 | 0.35 | 0.34 | 0.44 | 0.46 | 0.45 | 0.43 |
Cash ROIC |
5.49% | 5.67% | 2.76% | 16.85% | 20.32% | 10.07% | 8.08% | 11.01% | 10.79% | 11.85% |
Accounts Receivable Turnover |
5.36 | 5.53 | 5.29 | 9.02 | 8.38 | 5.67 | 5.53 | 5.03 | 6.39 | 6.44 |
Accounts Payable Turnover |
2.96 | 2.89 | 3.69 | 5.55 | 6.25 | 2.08 | 1.88 | 1.93 | 2.44 | 3.02 |
Inventory Turnover |
1.49 | 1.70 | 2.60 | 3.81 | 3.61 | 1.12 | 1.11 | 1.19 | 1.56 | 1.72 |
Average Days of Payables |
119.04 | 115.18 | 98.15 | 72.36 | 66.06 | 184.26 | 176.16 | 189.83 | 151.36 | 134.36 |
Days of Inventory on Hand |
242.03 | 221.87 | 149.03 | 95.45 | 107.28 | 345.04 | 320.32 | 304.93 | 246.35 | 200.92 |
Average Receivables |
11,668.50 | 11,514.50 | 11,259.00 | 11,215.50 | 9,696.00 | 7,342.50 | 7,398.50 | 8,123.00 | 8,223.00 | 8,200.50 |
Average Payables |
5,436.50 | 6,171.50 | 6,759.50 | 6,193.50 | 4,930.50 | 4,085.00 | 4,280.50 | 4,665.00 | 4,596.00 | 4,078.00 |
Average Inventory |
10,752.50 | 10,520.00 | 9,585.00 | 9,020.00 | 8,539.50 | 7,544.00 | 7,288.00 | 7,543.00 | 7,180.50 | 7,148.00 |
Average Assets |
210,778.00 | 219,948.50 | 211,853.00 | 189,340.50 | 167,852.50 | 160,911.50 | 163,508.00 | 165,609.50 | 171,706.00 | 169,498.00 |
Average Common Equity |
87,636.00 | 88,892.50 | 92,602.50 | 86,689.50 | 70,467.50 | 63,450.50 | 63,584.00 | 67,687.50 | 65,725.50 | 62,394.00 |
Columns are period end dates · fundamentals updated 5 Nov 2026